The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Vitamin and Mineral Supplement Use Among US Adults After Cancer Diagnosis: A Systematic Review
Abstract
Vitamin and mineral supplement use is thought to be common among the 10 million adults in the United States who have been diagnosed with cancer; however, well-conducted studies of this topic are sparse. Moreover, the biologic effects of supplement use among cancer survivors are not well established and not necessarily beneficial. We present a systematic summary of studies published between 1999 and 2006, 32 in total, addressing vitamin and mineral supplement use among US adult cancer patients and survivors. Supplement use is widespread among cancer patients and longer-term survivors. In studies combining different cancer sites, 64% to 81% of survivors reported using any vitamin or mineral supplements and 26% to 77% reported using any multivitamins. In contrast, approximately 50% of US adults use dietary supplements and 33% use multivitamin/multimineral supplements. Between 14% and 32% of survivors initiate supplement use after diagnosis, and use differs by cancer site. Breast cancer survivors reported the highest use, whereas prostate cancer survivors reported the least. Higher level of education and female sex emerged as factors most consistently associated with supplement use. Up to 68% of physicians are unaware of supplement use among their cancer patients. These results highlight the need for further studies of the association between dietary supplement use and cancer treatment toxicity, recurrence, survival, and quality of life to support evidence-based clinical guidelines for dietary supplement use among cancer patients and longer-term survivors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,774
Quality of Life in Long-Term, Disease-Free Survivors of Breast Cancer: a Follow-up Study
Ganz, P. A. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.1.39 · Cited by 1,060
Doyle, C., Kushi, L. H., Byers, T., Courneya, K. S., Demark-Wahnefried, W., Grant, B., McTiernan, A., Rock, C. L., Thompson, C., Gansler, T., et al. (2006) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.6.323 · Cited by 950
Folic Acid for the Prevention of Colorectal Adenomas: A Randomized Clinical Trial
Cole, B. F., Baron, J. A., Sandler, R. S., Haile, R. W., Ahnen, D. J., Bresalier, R. S., McKeown-Eyssen, G., Summers, R. W., Rothstein, R. I., Burke, C. A., et al. (2007) · JAMA · doi:10.1001/jama.297.21.2351 · Cited by 929
Radimer, K. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh207 · Cited by 818
Use of Alternative Medicine by Women with Early-Stage Breast Cancer
Burstein, H. J., Gelber, S., Guadagnoli, E., & Weeks, J. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906033402206 · Cited by 634
Effects of St. John's wort on irinotecan metabolism.
Mathijssen, R. H. J. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.16.1247 · Cited by 457
Effect of St John's Wort on Drug Metabolism by Induction of Cytochrome P450 3A4 Enzyme
Markowitz, J. S. (2003) · JAMA · doi:10.1001/jama.290.11.1500 · Cited by 403
Role of Folate in Colon Cancer Development and Progression
Kim, Y.-I. (2003) · The Journal of Nutrition · doi:10.1093/jn/133.11.3731s · Cited by 386
Alternative Therapies Used by Women With Breast Cancer in Four Ethnic Populations
Lee, M. M., Lin, S. S., Wrensch, M. R., Adler, S. R., & Eisenberg, D. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.1.42 · Cited by 373
Cited by
Nutrition and physical activity guidelines for cancer survivors
Rock, C. L., Doyle, C., Demark‐Wahnefried, W., Meyerhardt, J., Courneya, K. S., Schwartz, A. L., Bandera, E. V., Hamilton, K. K., Grant, B., McCullough, M., et al. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21142 · Cited by 1,995
“Dietary supplement use is reported by 52% of US adults(142) and studies report ranges between 64% and 81% among cancer survivors.(98,143) A recent systematic review indicates that 14% to 32% of cancer survivors initiate supplement use after their diagnosis.”
BackgroundWhy US adults use dietary supplements
Bailey, R. L., Gahche, J. J., Miller, P. E., Thomas, P. R., & Dwyer, J. T. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.2299 · Cited by 745
Integrative oncology: Addressing the global challenges of cancer prevention and treatment
Mao, J. J., Pillai, G. G., Andrade, C. J., Ligibel, J. A., Basu, P., Cohen, L., Khan, I. A., Mustian, K. M., Puthiyedath, R., Dhiman, K. S., et al. (2022) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21706 · Cited by 446
Adverse Effects of Nutraceuticals and Dietary Supplements
Ronis, M. J. J., Pedersen, K. B., & Watt, J. (2018) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010617-052844 · Cited by 360
Skeie, G., Braaten, T., Hjartåker, A., Lentjes, M., Amiano, P., Jakszyn, P., Pala, V, Palanca, A., Niekerk, E. M., Verhagen, H., et al. (2009) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2009.83 · Cited by 242
Tocaciu, S., Oliver, L. J., Lowenthal, R. M., Peterson, G. M., Patel, R., Shastri, M., McGuinness, G., Olesen, I., & Fitton, J. H. (2018) · Integrative Cancer Therapies · doi:10.1177/1534735416684014 · Cited by 71
Sesso, H. D., Rist, P. M., Aragaki, A. K., Rautiainen, S., Johnson, L. G., Friedenberg, G., Copeland, T., Clar, A., Mora, S., Moorthy, M. V., et al. (2022) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqac056 · Cited by 51
Metadata
- Authors
- Velicer, C. M., & Ulrich, C. M.
- Venue
- Journal of Clinical Oncology
- Published
- 2008-02-01
- Volume
- 26
- Issue
- 4
- Pages
- 665-673
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1981890034
- Cited by
- 357
- References
- 43
- FWCI
- 6.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.